Corporate Philanthropy - Best Practices at Novartis AG |
ICMR HOME | Case Studies Collection » Business Ethics Case Studies Please note: This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source. |
||||||||||
"One vital way of improving health conditions for poor people of the world is to establish strong partnerships involving all parties - governments, NGOs, the private sector and international organizations. The cooperation between The World Health Organization (WHO), the Novartis Foundation for Sustainable Development (NFSD) and Novartis to eliminate leprosy exemplifies this form of partnership."1 - Paul Hunt, UN Special Rapporteur on the Right to Health, in 2004. "We are committed to applying our core strengths in discovering, developing, producing and distributing high quality medicines to ensure that patients around the world receive the treatments they need."2 - Dr. Daniel Vasella, Chairman and CEO, Novartis, in 2005. Introduction
The award was given by the Committee to Encourage Corporate Philanthropy (CECP) in recognition of Novartis' efforts that benefited millions of poor patients across the world. CECP gave the award to companies that had demonstrated executive commitment and innovation in corporate philanthropy. In the year 2004, Novartis spent over US$ 570 million on philanthropic activities through a program called 'Access to Medicines'.
Corporate Philanthropy - Best Practices at Novartis AG - Next Page>>
1] Novartis Foundation for Sustainable Development
Celebrates 25th Anniversary with Symposium on the "Right to Health: A Duty
for Whom?"www.novartisfoundation.com, December 02, 2004. |
Case Studies Links:-
Case Studies,
Short Case Studies,
Simplified Case Studies.
Other Case Studies:-
Multimedia Case Studies,
Cases in Other Languages.
Business Reports Link:-
Business Reports.
Books:-
Textbooks,
Work Books,
Case Study Volumes.